Literature DB >> 2744789

Effect of serum concentration on hybridoma cell growth and monoclonal antibody production at various initial cell densities.

G M Lee1, T K Huard, B O Palsson.   

Abstract

Hybridoma cells (S3H5/gamma 2bA2) were cultivated using RPMI 1640 media with different serum concentrations at various initial cell densities. It was found that the serum requirement for cell growth was population-dependent. At an initial cell density of 1.10(4) cells/ml, the minimum serum concentration for cell growth was 5% (v/v) and reduced to 1% at the initial cell density of 1.10(5) cells/ml. When the initial density was increased to 1.10(6) cells/ml, serum was not needed for cell growth. The maximum cell density and the integral of viable cells over cultivation time increased as serum concentration or initial cell density was increased. However, specific antibody production rate was almost constant at 0.16 pg/cell.hr irrespective of serum concentration or initial cell density.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744789     DOI: 10.1089/hyb.1989.8.369

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  4 in total

1.  Hybridoma growth and productivity: effects of conditioned medium and of inoculum size.

Authors:  R L Dutton; J M Scharer; M Moo-Young
Journal:  Cytotechnology       Date:  1999-01       Impact factor: 2.058

2.  Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell.

Authors:  Sucharita Sen; Pradip K Roychoudhury
Journal:  Cytotechnology       Date:  2012-07-19       Impact factor: 2.058

3.  Enhanced specific antibody productivity of calcium alginate-entrapped hybridoma is cell line-specific.

Authors:  G M Lee; S J Kim; B O Palsson
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Effects of edible bird's nest (EBN) on cultured rabbit corneal keratocytes.

Authors:  Fadhilah Zainal Abidin; Chua Kien Hui; Ng Sook Luan; Elvy Suhana Mohd Ramli; Lee Ting Hun; Norzana Abd Ghafar
Journal:  BMC Complement Altern Med       Date:  2011-10-12       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.